Pentixapharm Holding AG (PTP)

BRIEF

published on 03/03/2025 at 14:43, 10 days 10 hours ago

Pentixapharm Holding AG Announces Board Changes

Supervisory Board Board Changes Leadership Transition Pentixapharm Governance Dr. Andreas Eckert
PRESS RELEASE

published on 03/03/2025 at 14:38, 10 days 10 hours ago

Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
Personnel changes in both the Supervisory Board and Management Board of Pentixapharm Holding AG have been implemented as of March 1, 2025, aligning the boards of the parent and subsidiary companies

Supervisory Board Management Board Berlin Personnel Changes Pentixapharm Holding AG
BRIEF

published on 02/13/2025 at 14:15, 1 month ago

Pentixapharm to Present Pioneering Bladder Cancer Treatment at ASCO-GU 2025

Bladder Cancer Lu177-PentixaTher CXCR4 Target ASCO-GU 2025 Radioligand Therapy
PRESS RELEASE

published on 02/13/2025 at 14:10, 1 month ago

First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025
Pentixapharm presents first-in-human data on Lu177-PentixaTher for Muscle-Invasive Bladder Cancer at ASCO-GU 2025, showing potential for bladder preservation and targeted treatment

Pentixapharm Lu177-PentixaTher ASCO-GU 2025 Muscle-Invasive Bladder Cancer Radioligand-Therapy
BRIEF

published on 01/24/2025 at 17:05, 1 month 20 days ago

Pentixapharm Holding AG Reports a EUR 14 Million Loss for 2024 Financial Year

Financial Loss 2024 Results Pentixapharm Myelo Therapeutics U.S. Funding
PRESS RELEASE

published on 01/24/2025 at 17:00, 1 month 20 days ago

EQS-Adhoc: Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million
Pentixapharm Holding AG reports a 2024 financial year loss of EUR 14 million, including risk provisions for Myelo. Find more details in the upcoming annual report

Annual Report Risk Provisions Pentixapharm Holding AG Financial Year Loss Myelo
BRIEF

published on 01/07/2025 at 10:35, 2 months 6 days ago

Pentixapharm Secures EUR 6.77 Million from Glycotope Assets

Transaction Pentixapharm Glycotope Pharmaceutical Acquisition Intangible Assets
PRESS RELEASE

published on 01/07/2025 at 10:30, 2 months 6 days ago

Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
Pentixapharm receives EUR 6.77 million for intangible assets formerly developed by Glycotope from undisclosed Asian pharma and biotech companies, eliminating remaining earn-out obligations

Acquisition Pharma Pentixapharm Glycotope Intangible Assets
BRIEF

published on 11/21/2024 at 11:05, 3 months 22 days ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
PRESS RELEASE

published on 11/21/2024 at 11:00, 3 months 22 days ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher

1 2 ... 4

Published on 03/13/2025 at 21:30, 3 hours 46 minutes ago

Star Royalties Highlights Copperstone Project Economics and Stream Valuation
Published on 03/13/2025 at 21:30, 3 hours 46 minutes ago

Relevant Gold Closes Second Tranche of Upsized $8.5 Million Non-Brokered Private Placement Led by Strategic Investors Kinross and Bollinger
Published on 03/13/2025 at 21:28, 3 hours 48 minutes ago

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth
Published on 03/13/2025 at 21:20, 3 hours 56 minutes ago

Fresh Vine Wine, Inc. To Change Corporate Name To Amaze Holdings, Inc. and Ticker Symbol to AMZE Following Strategic Acquisition
Published on 03/13/2025 at 21:15, 4 hours 1 minute ago

Kingstone Reports Record Fourth Quarter and Full Year 2024 Results

View all ACCESSWIRE

Published on 03/13/2025 at 20:58, 4 hours 17 minutes ago

EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT concludes bridge financing agreement. Changes in the Supervisory Board.
Published on 03/13/2025 at 19:49, 5 hours 26 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA increases forecast
Published on 03/13/2025 at 18:30, 6 hours 46 minutes ago

Swiss Prime Site: Annual General Meeting approves all proposals of the Board of Directors with a large majority
Published on 03/13/2025 at 17:55, 7 hours 20 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/13/2025 at 17:45, 7 hours 31 minutes ago

FIGEAC AÉRO: FIGEAC AÉRO INVESTS IN THE INDUSTRY OF THE FUTURE WITH THE SUPPORT OF FRANCE 2030 AND THE DGAC

View all EQS

Published on 03/13/2025 at 19:30, 5 hours 46 minutes ago

CDA - Sharholder Meeting report - March 13
Published on 03/13/2025 at 18:00, 7 hours 16 minutes ago

Air Liquide has successfully issued a 500 million euros green bond to finance the energy transition
Published on 03/13/2025 at 17:45, 7 hours 31 minutes ago

Press release Directors Board 13.03.2025
Published on 03/13/2025 at 17:45, 7 hours 31 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2025
Published on 03/13/2025 at 08:33, 16 hours 42 minutes ago

Safran - Update OCEANE 2028

View all LES ECHOS COMFI WIRE

News